An underlying characteristic in the pathophysiology of airway diseases such as asthma, COVID-19, or chronic bronchitis is inflammation mediated by pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNFα) [1,2,3,4,5]. This evidence concerns the gene TNF and COVID-19.